Discovery of a Highly Potent and Selective mTOR Inhibitor that Strongly Suppresses Glioblastoma Multiforme Cell Growth

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-04-13
DOI
https://doi.org/10.1021/acs.jmedchem.6c00541
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery of a Highly Potent and Selective mTOR Inhibitor that Strongly Suppresses Glioblastoma Multiforme Cell Growth

Margaret C. Frame, Jonathon Mok, John C. Dawson, Álvaro Lorente‐Macías et al.
Journal of Medicinal Chemistry
PI3K/AKT/mTOR signaling in cancer
article

Discovery of a Highly Potent and Selective mTOR Inhibitor that Strongly Suppresses Glioblastoma Multiforme Cell Growth

Margaret C. Frame, Jonathon Mok, John C. Dawson, Álvaro Lorente‐Macías, Neil O. Carragher, Asier Unciti-Broceta, Ana Juan-Albuquerque
article en

Abstract

No abstract available for this paper.
Journal of Medicinal ChemistryVol. 69(8)
Edinburgh Cancer Research (GB), University of Edinburgh (GB)
Scottish Government, Cancer Research UK, Brain Tumour Charity, Medical Research Council, Institute of Genetics
Good health and well-being
Openalex Percentile: Top 20%
PI3K/AKT/mTOR signaling in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.